Literature DB >> 16842452

Systematic review: the impact of gastro-oesophageal reflux disease on work productivity.

P Wahlqvist1, M C Reilly, A Barkun.   

Abstract

BACKGROUND: Gastro-oesophageal reflux disease has wide-ranging effects on patients' lives. AIM: To review systematically the effects of gastro-oesophageal reflux disease on work productivity.
METHODS: Studies of gastro-oesophageal reflux disease and work productivity were identified in a systematic literature search and their results were valued in US dollars using the human capital method. Work productivity loss was defined as absence from work (absenteeism) plus reduced effectiveness while working (presenteeism).
RESULTS: Eight eligible studies were included. Reported work productivity loss among individuals with gastro-oesophageal reflux disease ranged from 6% to 42% and was primarily because of presenteeism (6-40%) rather than absenteeism (<1% to 7%). Reported losses were greatest in patients experiencing sleep disturbance because of gastro-oesophageal reflux disease, and lowest in individuals from the general population taking appropriate prescription medication. Work productivity impairment correlated with symptom severity and responded to acid-suppressive therapy. Assuming a 40-h working week and average wages in the US, the weekly mean productivity loss per employee with gastro-oesophageal reflux disease can be estimated between 2.4 (62 dollars) and 16.6 h (430 dollars), depending on the population studied.
CONCLUSIONS: Gastro-oesophageal reflux disease has a substantial impact on employee productivity, primarily by impairing productivity while working. Further studies are needed to confirm that this impact can be decreased by acid-suppressive therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16842452     DOI: 10.1111/j.1365-2036.2006.02996.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  44 in total

1.  The value of branded proton pump inhibitors: formulary considerations.

Authors:  David A Peura; Rosemary R Berardi; Javier Gonzalez; Louis Brunetti
Journal:  P T       Date:  2011-07

2.  Acid control cannot be improved with a modified-release formulation of a proton pump inhibitor compared with twice-daily dosing of the conventional formulation.

Authors:  Kerstin Röhss; Clive Wilder-Smith; Sara Bokelund-Singh; Mohamed Sagar; Péter Nagy
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

3.  Effects of structured follow-up and of more effective acid inhibitory treatment in the management of GORD patients in a Swedish primary-care setting: a randomized, open-label study.

Authors:  Rickard Ekesbo; Svante Sjöstedt; Heléne Sörngård
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

4.  Endoscopic full-thickness plication for the treatment of GERD: Five-year long-term multicenter results.

Authors:  Douglas Pleskow; Richard Rothstein; Richard Kozarek; Gregory Haber; Christopher Gostout; Simon Lo; Robert Hawes; Anthony Lembo
Journal:  Surg Endosc       Date:  2007-11-20       Impact factor: 4.584

Review 5.  Employee health and presenteeism: a systematic review.

Authors:  Alyssa B Schultz; Dee W Edington
Journal:  J Occup Rehabil       Date:  2007-07-25

6.  Shedding light on the epidemiology of gastroesophageal reflux disease in India--a big step forward.

Authors:  Srinivas Gaddam; Prateek Sharma
Journal:  Indian J Gastroenterol       Date:  2011-07-23

7.  Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.

Authors:  Samira Toghanian; David A Johnson; Nils-Olov Stålhammar; Frank Zerbib
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

8.  More art than science: impedance analysis prone to interpretation error.

Authors:  Thomas Ciecierega; Benjamin L Gordon; Anna Aronova; Carl V Crawford; Rasa Zarnegar
Journal:  J Gastrointest Surg       Date:  2015-04-16       Impact factor: 3.452

9.  Intercellular space volume is mainly increased in the basal layer of esophageal squamous epithelium in patients with GERD.

Authors:  Helmut Neumann; Klaus Mönkemüller; Lucía C Fry; Frank Dombrowski; Doerthe Kuester; Mike Beyer; Peter Malfertheiner
Journal:  Dig Dis Sci       Date:  2010-10-30       Impact factor: 3.199

10.  Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study.

Authors:  Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Nuevo
Journal:  Health Qual Life Outcomes       Date:  2009-10-16       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.